Curtis A. Lachowiez

Statistics

Publications

Citations

1.3K

H-Index

Active since

2020

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Oregon Health & Science University

Dana-Farber Cancer Institute

University of Oxford

UNC Lineberger Comprehensive Cancer Center

Curtis A. Lachowiez is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, hematologic malignancy therapy, and oncology.

ORCID

Publications per year

2020–2025

Publications

Venetoclax Combined With FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia

Courtney D. DiNardo, Curtis A. Lachowiez, Koichi Takahashi et al. · Journal of Clinical Oncology · 2021 · 334 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Outcomes of older patients with NPM1-mutated AML: current treatments and the promise of venetoclax-based regimens

Curtis A. Lachowiez, Sanam Loghavi, Tapan M. Kadia et al. · Blood Advances · 2020 · 156 citations · Full text

Medicine, Hematology, Oncology +12

A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in <i>IDH1</i> -Mutated Myeloid Malignancies

Curtis A. Lachowiez, Sanam Loghavi, Zhihong Zeng et al. · Blood Cancer Discovery · 2023 · 122 citations · Full text

Medicine, Hematology, Pharmacology +11

Venetoclax combined with <scp>FLAG‐IDA</scp> induction and consolidation in newly diagnosed acute myeloid leukemia

Courtney D. DiNardo, Curtis A. Lachowiez, Koichi Takahashi et al. · American Journal of Hematology · 2022 · 94 citations · Full text

Medicine, Oncology, Pharmacology +15

Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia

Curtis A. Lachowiez, Nicola Long, Jennifer N. Saultz et al. · Blood Advances · 2022 · 92 citations · Full text

Medicine, Hematology, Oncology +13

1–5 of 21